Mirkos Ortiz Martins

Dr. Mirkos Ortiz Martins

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in Structural Chemistry
Verified
Journal Article
Open access
PDF file
JSJúlia Vaz Schultz
Júlia Vaz Schultz
MTMariana Zancan Tonel
Mariana Zancan Tonel
MMMirkos Ortiz Martins
Mirkos Ortiz Martins
SFSolange Binotto Fagan
Solange Binotto Fagan
Nanocarriers allow the connection between biomolecules and other structures to enhance the treatment efficacy, through the biomolecule’s properties to an existing drug, or to allow a better and specific delivery. Apigenin and orientin are biomolecules with excellent therapeutic properties that are proposed in the fight against COVID-19. Besides that, graphene oxide is a nanomaterial that exhibits antiviral activity and is used as a nanocarrier of several drugs. We evaluated in this work, through molecular docking, the binding affinity between these structures to the receptor-binding domain of spike protein of two coronavirus variants, Delta and Omicron. The results indicate that all the structures exhibit affinity with the two protein targets, with binding affinity values of −11.88 to −6.65 kcal/mol for the Delta variant and values of −9.58 to −13.20 kcal/mol for the Omicron variant, which is a successful value as found in the literature as a potential inhibitor of SARS-CoV-2 infection. Also, through first-principles calculations based on Density Functional Theory, the interaction of graphene oxide with the biomolecules apigenin and orientin occurred. The results exhibit weak binding energy, which indicates that physical adsorption occurs, with better results when the biomolecule is set in parallel to the nanomaterial due to attractive π-π staking. These results are conducive to the development of a nanocarrier.

10 June 2022 in Disciplinarum Scientia - Ciências Naturais e Tecnológicas
Verified
Journal Article
Open access
PDF file
ASAndré Flores dos Santos
André Flores dos Santos
MMMirkos Ortiz Martins
Mirkos Ortiz Martins
GMGiane Engel Montagner
Giane Engel Montagner
JSJúlia Vaz Schultz
Júlia Vaz Schultz
PGPatrícia Gomes
Patrícia Gomes
SFSolange Binotto Fagan
Solange Binotto Fagan
In March 2020, it was declared a coronavirus (COVID-19) pandemic disease state by the World Health Organization, which represents a public health concern. Several antiviral and non-antiviral drugs are currently being tested against the COVID-19 disease, some of which have already been approved by health regulatory bodies in some countries. In this study, the objective was to identify the best drugs that are being used to fight the virus through computer simulations in addition to predicting toxicity and antiviral activity. Thus, molecular docking of the compounds arbidol, baricitinib, camostat mesylate, favipiravir, heparin, hydroxychloroquine, molnupiravir, paxlovid, and remdesivir was performed to discover the best points of interaction in the cellular organelles involved in the process of cellular infection by SARS-CoV- 2 and the prediction of toxicology and antiviral activity of the compounds was performed by online computer simulation programs: pkCSM, ProTox-II, GUSAR, ROSC-Pred, and AntiVir-Pred. The best results highlight the drugs heparin as a good protein S blocker, paxlovid as a protease inhibitor, arbidol as a viral entry blocker, baricitinib as an RNA replication inhibitor, and membrane fusion inhibitor. All compounds showed a low risk of toxicity, as most showed antiviral activity. Thus, all compounds, except favipiravir, demonstrated some type of interaction with target cell organelles, but more studies are needed, such as in vitro and in vivo, to obtain reliable results for treatment with small doses of the drug, since the prediction showed small rates of the toxicity, mainly hepatic.

7 July 2023 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
ASAndré Flores dos Santos
André Flores dos Santos
MMMirkos Ortiz Martins
Mirkos Ortiz Martins
JLJeronimo Lameira
Jeronimo Lameira
JAJéssica de Oliveira Araújo
Jéssica de Oliveira Araújo
MFMarcela Sagrilo Frizzo
Marcela Sagrilo Frizzo
SFSolange Binotto Fagan
Solange Binotto Fagan

24 March 2021 in Biophysica
Verified
Journal Article
Open access
PDF file
PSPatricia Ferreira Schopf
Patricia Ferreira Schopf
IZIvana Zanella
Ivana Zanella
Maria Natalia Dias Soeiro CordeiroMaria Natalia Dias Soeiro Cordeiro
Maria Natalia Dias Soeiro Cordeiro
JRJuan Ruso
Juan Ruso
MGMichael Gonzàlez-Durruhty
Michael Gonzàlez-Durruhty
MMMirkos Ortiz Martins
Mirkos Ortiz Martins
The tau protein is considered an important qualitative and quantitative biomarker for Alzheimer’s disease in its asymptomatic phase. In 2011, biomarkers were suggested by the National Institute on Aging-Azheimer’s Association as a new criterion for the early diagnosis of Alzheimer’s disease. Thus, highlighting the non-existence of theoretical research on the subject, we investigated the binding interaction properties between phosphorylated tau protein and a theoretically modeled ligands constituted by the fullerol functionalized with radiopharmaceuticals from an in silico approach via molecular docking and density functional theory (DFT) ab initio computational simulation. The results demonstrated that the ligand with the greatest affinity-based binding energy to the protein was fullerol + F-THK5105. However, all systems were considered promising for the development of a potential diagnostic nanomarker. These theoretical results could efficiently contribute to reduce the time and the cost for future experimental preclinical studies and open new opportunities toward molecular recognition in nanomedicine.

29 December 2021 in Disciplinarum Scientia - Ciências Naturais e Tecnológicas
Verified
Journal Article
Open access
PDF file
MMMirkos Ortiz Martins
Mirkos Ortiz Martins
ISIvana Zanella Da Silva
Ivana Zanella Da Silva
SFSolange Binotto Fagan
Solange Binotto Fagan
ASAndré Flores Dos Santos
André Flores Dos Santos
This work reviews the literature on the molecular docking process, presenting the simulation methodology, the construction parameters and how the results are interpreted. In this context, a study of molecular docking is carried out using the binding protein of the COVID-19 virus with the human cell, called spike, and an antiviral molecule called heparin. As a result, the parameters reached, distances, energies and three-dimensional positioning of the ligand-receptor system are shown. This type of work is currently done in the area of discovering new drugs, or drugs discovered with the aid of the computer. As a final discussion, it concludes the importance of computational knowledge as a way to support various chemical, physical and biological activities in the multidisciplinary field of nanoscience and nanotechnology.

10 November 2017
Verified
Book Chapter
Closed access
PDF file
MMMirkos Ortiz Martins
Mirkos Ortiz Martins
DBDante Barone
Dante Barone